{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:14:30Z","timestamp":1767212070175,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jpba.2021.113891","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T08:16:57Z","timestamp":1610093817000},"page":"113891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Interaction of citalopram and escitalopram with calf Thymus DNA: A spectrofluorometric, voltammetric, and liquid chromatographic approach"],"prefix":"10.1016","volume":"195","author":[{"given":"\u00c7i\u011fdem Kanbe\u015f","family":"Dindar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Erkmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sercan","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2525-4192","authenticated-orcid":false,"given":"Burcin","family":"Bozal-Palabiyik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7327-4913","authenticated-orcid":false,"given":"Bengi","family":"Uslu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2021.113891_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.dyepig.2017.09.051","article-title":"Synthesis, DNA\/BSA binding and DNA photocleavage properties of water soluble BODIPY dyes","volume":"148","author":"Biyiklioglu","year":"2018","journal-title":"Dyes Pigm."},{"key":"10.1016\/j.jpba.2021.113891_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2020.107630","article-title":"Interactions of lamotrigine with single- and double-stranded DNA under physiological conditions","author":"Morawska","year":"2020","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.jpba.2021.113891_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2017.05.014","article-title":"Unravelling the interaction of pirenzepine, a gastrointestinal disorder drug, with calf thymus DNA: an in vitro and molecular modelling study","volume":"625\u2013626","author":"Rahman","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jpba.2021.113891_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jphotobiol.2012.07.003","article-title":"Chemistry of DNA minor groove binding agents","volume":"115","author":"Shahzada Khan","year":"2012","journal-title":"J. Photochem. Photobiol. B, Biol."},{"key":"10.1016\/j.jpba.2021.113891_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1002347","article-title":"Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer","volume":"8","author":"Shigemizu","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jpba.2021.113891_bib0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1345\/aph.19137","article-title":"Citalopram in the treatment of depression","volume":"34","author":"Parker","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jpba.2021.113891_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4760","article-title":"Recent advances in liquid chromatographic methods for the determination of selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors","volume":"34","author":"Jia","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2021.113891_bib0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/sscp.201900021","article-title":"Comparative study of different chemistries and particle properties, high\u2010performance liquid chromatography stationary phases in separation of escitalopram oxalate and its impurities in different pharmaceutical dosage forms","volume":"2","author":"Badulla","year":"2019","journal-title":"Sep. Sci. Plus."},{"key":"10.1016\/j.jpba.2021.113891_bib0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/chir.23139","article-title":"Analytical methodologies for the enantiodetermination of citalopram and its metabolites","volume":"32","author":"Bud\u0103u","year":"2020","journal-title":"Chirality"},{"key":"10.1016\/j.jpba.2021.113891_bib0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/17425255.2014.863873","article-title":"Clinical pharmacology review of escitalopram for the treatment of depression","volume":"10","author":"Pastoor","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpba.2021.113891_bib0055","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1158\/0008-5472.CAN-13-3540","article-title":"Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling","volume":"74","author":"Van Noort","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpba.2021.113891_bib0060","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2174\/1871520617666170327155930","article-title":"Anti-cancer effects of citalopram on hepatocellular carcinoma cells occur via cytochrome c release and the activation of NF-kB","volume":"17","author":"Ahmadian","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.jpba.2021.113891_bib0065","first-page":"3376","article-title":"Escitalopram oxalate inhibits proliferation and migration and induces apoptosis in non-small cell lung cancer cells","volume":"15","author":"Yuan","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jpba.2021.113891_bib0070","first-page":"42789","article-title":"Assessment of citalopram and escitalopram on neuroblastoma cell lines","volume":"8","author":"Sakka","year":"2017","journal-title":"Cell Toxicity Gene Modulation Oncotarget"},{"key":"10.1016\/j.jpba.2021.113891_bib0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/jcmm.13372","article-title":"Escitalopram oxalate induces apoptosis in U-87MG cells and autophagy in GBM8401 cells","volume":"22","author":"Chen","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jpba.2021.113891_bib0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jphotobiol.2013.03.015","article-title":"Interaction of anticancer drug mitoxantrone with DNA hexamer sequence d-(CTCGAG)2 by absorption, fluorescence and circular dichroism spectroscopy","volume":"123","author":"Dogra","year":"2013","journal-title":"J. Photochem. Photobiol. B, Biol."},{"key":"10.1016\/j.jpba.2021.113891_bib0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bioelechem.2018.12.007","article-title":"Electrochemical, spectroscopic and molecular docking studies on the interaction of calcium channel blockers with dsDNA","volume":"127","author":"Shahzad","year":"2019","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.jpba.2021.113891_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmr.2735","article-title":"Study on the interaction of antidiabetic drug Pioglitazone with calf thymus DNA using spectroscopic techniques","volume":"31","author":"Al Qumaizi","year":"2018","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.jpba.2021.113891_bib0095","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s12010-013-0255-6","article-title":"In vitro evaluation of Zn-norfloxacin complex as a potent cytotoxic and antibacterial agent, proposed model for DNA binding","volume":"170","author":"Ahmadi","year":"2013","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.jpba.2021.113891_bib0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.molliq.2019.03.018","article-title":"Interaction of isoeugenol with calf thymus DNA and its protective effect on DNA oxidative damage","volume":"282","author":"Wang","year":"2019","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jpba.2021.113891_bib0105","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1039\/D0AN00209G","article-title":"Fluorescence chemosensing of meldonium using a cross-reactive sensor array","volume":"145","author":"Yalcin","year":"2020","journal-title":"Analyst"},{"key":"10.1016\/j.jpba.2021.113891_bib0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.snb.2013.12.088","article-title":"Investigation of anticancer drug lapatinib and its interaction with dsDNA by electrochemical and spectroscopic techniques","volume":"194","author":"Dogan-Topal","year":"2014","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.jpba.2021.113891_bib0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpha.2020.08.004","article-title":"Electrochemical, spectroscopic, and molecular docking studies of the interaction between the anti-retroviral drug Indinavir and dsDNA","volume":"10","author":"Mollarasouli","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jpba.2021.113891_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2020.107579","article-title":"An electrochemical study of 9-chloroacridine redox behavior and its interaction with double-stranded DNA","volume":"135","author":"Rupar","year":"2020","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.jpba.2021.113891_bib0125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jphotobiol.2012.12.015","article-title":"Characterization and DNA binding studies of unexplored imidazolidines by electronic absorption spectroscopy and cyclic voltammetry","volume":"120","author":"Shah","year":"2013","journal-title":"J. Photochem. Photobiol. B, Biol."},{"key":"10.1016\/j.jpba.2021.113891_bib0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ecoenv.2014.02.018","article-title":"Proposed model for binding of permethrin and deltamethrin insecticides with ct-DNA, a structural comparative study","volume":"106","author":"Ahmadi","year":"2014","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.jpba.2021.113891_bib0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jorganchem.2014.05.013","article-title":"Organometallic ruthenium(II) scorpionate as topo II\u03b1 inhibitor; in vitro binding studies with DNA, HPLC analysis and its anticancer activity","volume":"771","author":"Khan","year":"2014","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jpba.2021.113891_bib0140","first-page":"1023","article-title":"Evaluation of interaction between DNA and anticancer drug temozolomide and its degradation product by HPLC","volume":"63","author":"Kapcak","year":"2018","journal-title":"Rev. Roum. Chim."},{"key":"10.1016\/j.jpba.2021.113891_bib0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/elan.201000516","article-title":"Voltammetry and spectroscopy study of in vitro interaction of Fenitrothion with DNA","volume":"23","author":"Ahmadi","year":"2011","journal-title":"Electroanalysis"},{"key":"10.1016\/j.jpba.2021.113891_bib0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.synthmet.2017.05.006","article-title":"Water soluble axially morpholine disubstituted silicon phthalocyanines: synthesis, characterisation, DNA\/BSA binding, DNA photocleavage properties","volume":"229","author":"Barut","year":"2017","journal-title":"Synth. Met."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:11:24Z","timestamp":1760001084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":30,"alternative-id":["S0731708521000030"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.113891","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction of citalopram and escitalopram with calf Thymus DNA: A spectrofluorometric, voltammetric, and liquid chromatographic approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.113891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113891"}}